CDXS - Codexis appoints former Eiger BioPharmaceuticals CFO as its finance chief
- Enzyme engineering company Codexis ( NASDAQ: CDXS ) on Monday said it had appointed Sri Ryali as CFO, effective immediately.
- The company said Ryali had most recently served as the CFO of Eiger BioPharmaceuticals ( EIGR ).
- Ryali also held positions in companies such as Jazz Pharmaceuticals ( JAZZ ) and Amgen ( AMGN ), CDXS said.
- Codexis ( CDXS ) stock earlier closed +3.8% at $6.76.
For further details see:
Codexis appoints former Eiger BioPharmaceuticals CFO as its finance chief